Kabotegravir
Economic Operator with Whom the Contract Has Been Concluded
| Show detail | ||||||||
|---|---|---|---|---|---|---|---|---|
| 937/2024-SML | 07. 05. 2024 | GlaxoSmithKline, s.r.o. | 30 308 940,48 | 27 061 554,00 | 30 308 940,48 | 27 061 554,00 | CZK |
Published Documents
| Show detail | |||||
|---|---|---|---|---|---|
| 01_Písemná zpráva zadavatele_Kabotegravir_EP.pdf | Písemná zpráva zadavatele | 13. 05. 2024 11:27 | Dokument není zavirovaný |
List of Participants
| Show detail | ||||||
|---|---|---|---|---|---|---|
| GlaxoSmithKline, s.r.o. | Praha | 30 308 940,48 | 27 061 554,00 | CZK |